Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Genetics Portfolio (Molecular Gen of HIV & HCV)
NIDA Genetics Programs
 
Return to Home Page
About Genetics Workgroup
Human Genetics Application Guidelines
NIDA Genetics News
NIDA Genetics Consortium
NIDA Recent Findings
NIDA Genetics Portfolio
NIDA Initiatives in Genetics
NIDA Meetings
NIDA Program Contacts
 

Resources for Genetics, Cell Biology, and Neuroscience
 
Calendar
Human Genetics
Tissue and Cell Repositories
Twin Registry
Nucleotide
Gene Expression
Genomes
Proteins
Model Organisms
Mouse
Knowledgebase for Addiction Related Genes (KARG)
Cell Biology
SfN Neuroscience Database
Gateway
Bibliographic Resources
 

Main Portfolio Index > 2004 Genetic Index >Molecular Gen of HIV & HCV

Molecular Gen of HIV & HCV Portfolio Listing A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
* No Names at this time

Back to previous page


 
*
BRANCH, ANDREA HCV Alternate Reading Frame Protein in HIV/HCV Co-infect
  1R01DA016156-01A1
   
BEAGLES, KAREN Gene expression in leukocytes after morphine treatment
  5F31DA015589-02
   
BIDLACK, JEAN Opioid REceptors on Lymphocytes and Brain
  2K05DA000360-06
   
BAYER, BARBARA Lymphocyte Activity During Stress: Effects of Morphine
  2R01DA004358-15

Back to previous page


 
*
CHANG, SULIE Morphine Actions on the Immune System
  1K02DA016149-01
   
CHANG, SULIE Morphine Actions on the Immune System
  5R01DA007058-13
   
CHENEY, PAUL NEURO-AIDS IN OPIATE DEPENDENT RHESUS MACAQUES
  R01DA012827-04

Back to previous page


 
*
   
   
   
   
   

Back to previous page


 
*
EISENSTEIN, TOBY Opioid Dependence, Immunity and Infection
  5R01DA014223-03

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
GABUZDA, DANA Monocyte Viral Reservoirs in HIV-1 Dementia
  1R01DA016549-01
   
GRAHAM, CAMILLA Cellular Immunity to Hepatitis C Virus in HIV
  5K08DA014495-03
   
GROOPMAN, JEROME Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
  5R01DA015008-03

Back to previous page


 

*
HERSHOW, RONALD EARLY NATURAL HISTORY OF HCV INFECTION AMONG IDUS
  5R01DA013765-03


Back to previous page


 
* No Names at this time.

Back to previous page


 
*

No Names at this time.

Back to previous page


 
*
KALDOR, JOHN Longitudinal cohort of newly acquired HCV infection
  1R01DA015999-01
   
KAMINSKI, NORBERT CB1/CB2-DEPENDENT AND -INDEPENDENT T CELL MODULATION
  2R01DA007908-11
   
KAMINSKI, NORBERT REPRESSION OF T CELL ACTIVATION BY ENDOCANNABINOIDS
  5R01DA012740-04
   
KATZE, MICHAEL Functional Genomics and HCV-Associated Liver Disease
  5P30DA015625-02
   
KLEIN, ROBERT NATURAL HISTORY OF HCV INFECTION IN DRUG USERS
  5R01DA013248-05
   
KLEIN, THOMAS CANNABINOID RECEPTORS ON IMMUNE CELLS
  5R01DA010683-06

Back to previous page


 
*
LAMA, JUAN ROLE OF CD4 DOWNMODULATION DURING HIV INFECTION
  5R01DA013866-04
   
LANDAU, NATHANIEL Murine Model for HIV-1 Replication
  5R01DA014494-02
   
LI, KUI Impact of HCV NS3/4A Protease on Host Innate Immunity
  1R21DA018054-01

Back to previous page


 

*
MARKHAM, RICHARD DRUG ABUSE AND RESISTANCE TO ANTIRETROVIRAL THERAPY
  5R01DA013347-04
   
MOHAMADZADEH, MANSOUR Dendritic cell targeted hepatitis c virus immunotherapy
  5R21DA016029-02

Back to previous page


 
*
NAGARKATTI, MITZI Cannabinoid-induced apoptosis of immune cells
  5R21DA014885-02
   
NAGARKATTI, PRAKASH Cannabinoid-induced apoptosis in T cell regulation
  1R01DA016545-01
   
NAIR, MADHAVEN HEROIN AIDS ENCEPHALOPATHY--NEUROPATHOGENESIS MECHANISMS
  5R01DA014218-03
   
NAIR, MADHAVEN AIDS encephalopathy and HIV disease: role of opioids
  5R01DA015628-02

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
PACHUK, CATHERINE Identification of novel antiviral targets using RNAi
  1R41DA016390-01
   
PAGE, JOHN HIV INFECTION POTENTIAL /IDU-RELATED INJECTION MATERIALS
  5R01DA012580-03

Back to previous page


 
  No Names at this time

Back to previous page


 
*
ROGERS, THOMAS HIV INFECTION AND OPIOID-INDUCED IMMUNOREGULATION
  1R01DA016544-01A1
   
ROY, SABITA MU-OPIOID RECEPTOR IN STRESS INDUCED IMMUNOSUPRESSION
  2P50DA011806-060010
   
ROY, SABITA Mu Opioid Receptor and Immune Function
  2R01DA012104-05A1

Back to previous page


 
*
SCHWARZ, KATHLEEN VIRAL HEPATITIS IN CHILDREN OF INJECTION DRUG USERS
  5R01DA013743-04
   
SHAPSHAK, PAUL GENE EXPRESSION IN HIV ASSOCIATED DEMENTIA BRAIN
  5R21DA014533-02
   
SHARP, BURT OPIATE RECEPTOR MEDIATED EFFECTS OF STRESS ON IMMUNITY
  5R01DA004196-18
   
SUHADOLNIK, ROBERT EFFECT OF OPIOIDS ON 2-5OAS/PKR PATHWAY IN HIV INFECTION
  5R01DA014240-03

Back to previous page


 
*
TAYLOR, ETHAN SELENOPROTEINS, NF-KB, AND HIV DISEASE IN IV DRUG USERS
  5R01DA013561-04
   
TASHKIN, DONALD Cocaine Smoking Effects on Lung Immunity & Host Defense
  2R01DA008254-09A1
   
TASHKIN, DONALD PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA
  5R37DA003018-22
   
THIO, CHLOE HEPATITIS C CLEARANCE AND HOST GENETIC FACTORS
  5K08DA000441-04
   
THOMAS, DAVID HEPATITIS C PATHOGENESIS & THE HUMAN GENOME
  5R01DA013324-05
   
TORBENSON, MICHAEL Occult Hepatitis B
  1K08DA016370-01

Back to previous page

 
* No Names at this time.

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
WILSON, DARCY Mimic Peptides of HIV-1 Epitopes as Vaccines
  5R43DA015212-02
   
WRIGHT, TERESA HCV VARIANTS AND IMMUNE RESPONSE IN INJECTION DRUG USERS
  5R01DA013737-04

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
YEN, T S Hepatitis C virus NS5A protein and lipid droplets
  5R21DA016023-02
   
YEOMANS, DAVID Recombinant Herpes Injection into Trigeminal Ganglia
  1R21DA016393-01
   
YU, XIAO-FANG VIRAL & HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS
  5R01DA013918-04
   
YU, XIAO-FANG Implications of HIV in Low HCV Clearance in Chinese IDUs
  1R01DA016540-01A1

Back to previous page


 
* No Names at this time.

Back to previous page


 
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Return to top
 
 
 
 
Any questions or concerns regarding the genetics programs please contact Jonathan D. Pollock Ph.D. (301) 443-1887 or jp183r@nih.gov


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, March 11, 2008. The U.S. government's official web portal